Rhodiola rosea, less commonly known as Rhodiola, Roseroot, Rosenroot, Golden Root, Arctic Root, or Orpin Rose (Panossian, Wikman & Sarria, 2010), grows in high altitudes throughout the mountainous regions of Europe and Asia (Brown, Gerbarg, & Ramazanov, 2002). Due to its ability to promote resistance to chemical, physical and biological stressors, Rhodiola rosea was designated an adaptogen by Russian scientists (Kelly, 2001). Some researchers believe that Rhodiola rosea use dates back to the Vikings as a medicinal compound used to enhance vigorous and strenuous work (Panossian et al., 2010). Since 1961 there have been more than 180 studies on the adaptogen’s pharmacological, phytochemical and clinical effects (Panossian et al., 2010), however the majority of modern research has been conducted in Russia and Scandinavia (Kelly, 2001). In traditional medicine Rhodiola rosea has been used to “increase physical endurance, work productivity, longevity, resistance to high altitude sickness, and to treat fatigue, depression, anemia, impotence, gastrointestinal ailments, infections, and nervous system disorders” (Brown et al., 2002, p. 41).
Benefits and Effects
- Reduces burn-out, mental fatigue and cortisol levels associated with stress (Darbinyan et al., 2000; Olsson et al., 2009; Spasov et al., 2000);
- Promotes cognition through neuroprotective, antioxidant, stimulatory yet emotionally calming effects, reduces forgetfulness, memory impairment, irritability, inability to concentrate, and cognitive deficits associated with Alzheimer’s (Qu et al., 2009; Walker & Robergs, 2006; Fintelmann & Gruenwald, 2007; Khanum, et al., 2005);
- Promotes a sense of general well-being and reduces depression (Brown et al., 2002; Panossian et al., 2010; Khanum et al., 2005);
- Improves exercise endurance capacity, work capacity and cardiovascular functioning (De Bock et al., 2004; Spasov et al., 2000; Kelly, 2001).
360-600 mg standardized for 1-percent rosavin
180-300 mg standardized for 2-percent rosavin
100-170 mg standardized for 3.6-percent rosavin
Brown, R. P., Gerbarg, P. L., & Ramazanov, Z. (2002). Rhodiola rosea. A phytomedicinal overview. HerbalGram, 56, 40-52. Retrieved from https://realdosestatic.com/common/info/research/Rhodiola-Phytomedicinal-Overview-Brown-Gerbarg.pdf
Darbinyan, V., Kteyan, A., Panossian, A., Gabrielian, E., Wikman, G., & Wagner, H. (2000). Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, 7(5), 365-371. doi: 10.1016/S0944-7113(00)80055-0
De Bock, K., Eijnde, B. O., Ramaekers, M., & Hespel, P. (2004). Acute Rhodiola rosea intake can improve endurance exercise performance. International journal of sport nutrition and exercise metabolism, 14(3), 298-307. doi: 10.1123/ijsnem.14.3.298
Fintelmann, V., & Gruenwald, J. (2007). Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies. Advances in therapy, 24(4), 929-939. doi: 10.1007/BF02849986
Khanum, F., Bawa, A. S., & Singh, B. (2005). Rhodiola rosea: a versatile adaptogen. Comprehensive reviews in food science and food safety, 4(3), 55-62. doi: 10.1111/j.1541-4337.2005.tb00073.
Kelly, G. (2001). Rhodiola rosea: a possible plant adaptogen. Altern Med Rev, 6(3), 293-302. Retrieved from http://www.brainlife.org/fulltext/2001/kelly_gs010600.pdf
Olsson, E. M., von Schéele, B., & Panossian, A. G. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta medica, 75(02), 105-112. Doi: 10.1055/s-0028-1088346
Panossian, A., Wikman, G., & Sarris, J. (2010). Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine, 17(7), 481-493. doi: 10.1016/j.phymed.2010.02.002
Qu, Z. Q., Zhou, Y., Zeng, Y. S., Li, Y., & Chung, P. (2009). Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: implication of anti-oxidative and neuroprotective effects. Biomedical and environmental sciences, 22(4), 318-326. doi: 10.1016/S0895-3988(09)60062-3
Spasov, A. A., Wikman, G. K., Mandrikov, V. B., Mironova, I. A., & Neumoin, V. V. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 7(2), 85-89. doi: 10.1016/S0944-7113(00)80078-1
Walker, T. B., & Robergs, R. A. (2006). Does Rhodiola rosea possess ergogenic properties?. International journal of sport nutrition and exercise metabolism, 16(3), 305-315. doi: 10.1123/ijsnem.16.3.305